34 related articles for article (PubMed ID: 38623586)
1. Thymosin α1 combined with XELOX improves immune function and reduces serum tumor markers in colorectal cancer patients after radical surgery.
Sha L; Zhang H; Zhang X
Open Life Sci; 2024; 19(1):20220793. PubMed ID: 38623586
[TBL] [Abstract][Full Text] [Related]
2. Evaluating combined bevacizumab and XELOX in advanced colorectal cancer: Serum markers carcinoembryonic antigen, carbohydrate antigen 125, carbohydrate antigen 199 analysis.
Zhou DB; Cheng J; Zhang XH
World J Clin Cases; 2024 Jan; 12(1):15-23. PubMed ID: 38292648
[TBL] [Abstract][Full Text] [Related]
3. DC-CIK combined with chemotherapy on the efficacy, immune function, and life quality in colorectal cancer patients after radical resection.
Lu D; Li T; Yang Z; Zhao X; Su Y; Nian L
Am J Transl Res; 2023; 15(4):2793-2801. PubMed ID: 37193178
[TBL] [Abstract][Full Text] [Related]
4. Effects of natural orifice transluminal endoscopic radical resection of the colon and targeted therapy on immune response and blood CA199 and CA242 levels in colorectal cancer.
Liu G; Liu J; Ren W; Yang L; Guo Q; Ye H
Medicine (Baltimore); 2023 Nov; 102(47):e35949. PubMed ID: 38013346
[TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy and safety of Chinese medicine injections combined with capecitabine and oxaliplatin chemotherapies in treatment of colorectal cancer: A bayesian network meta-analysis.
Liu S; Zhang K; Hu X
Front Pharmacol; 2022; 13():1004259. PubMed ID: 36523501
[No Abstract] [Full Text] [Related]
6. [Effect of continuous blood purification and thymosin alpha1 on the cellular immunity in patients with severe sepsis: a prospective, randomized, controlled clinical trial].
Li YN; Zhou LX; Qiang XH; Yu TO; Mao KJ; Feng B; Wen WB; Zou YC; Li WY; Li C
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2009 Mar; 21(3):139-42. PubMed ID: 19278581
[TBL] [Abstract][Full Text] [Related]
7. Utility and specificity of plasma heat shock protein 90 alpha, CEA, and CA199 as the diagnostic test in colorectal cancer liver metastasis.
Ding Q; Sun Y; Zhang J; Yao Y; Huang D; Jiang Y
J Gastrointest Oncol; 2022 Oct; 13(5):2497-2504. PubMed ID: 36388698
[TBL] [Abstract][Full Text] [Related]
8. Thymosin alpha 1 as an adjuvant to hyperthermic intraperitoneal chemotherapy in an experimental model of peritoneal metastases from colonic carcinoma.
Nevo N; Lee Goldstein A; Bar-David S; Natanson M; Alon G; Lahat G; Nizri E
Int Immunopharmacol; 2022 Oct; 111():109166. PubMed ID: 35994852
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Thymosin α1 in Management of Radiation Pneumonitis in Patients With Locally Advanced Non-Small Cell Lung Cancer Treated With Concurrent Chemoradiotherapy: A Phase 2 Clinical Trial (GASTO-1043).
Liu F; Qiu B; Xi Y; Luo Y; Luo Q; Wu Y; Chen N; Zhou R; Guo J; Wu Q; Xiong M; Liu H
Int J Radiat Oncol Biol Phys; 2022 Nov; 114(3):433-443. PubMed ID: 35870709
[TBL] [Abstract][Full Text] [Related]
10. Immune enhancement in patients with predicted severe acute necrotising pancreatitis: a multicentre double-blind randomised controlled trial.
Ke L; Zhou J; Mao W; Chen T; Zhu Y; Pan X; Mei H; Singh V; Buxbaum J; Doig G; He C; Gu W; Lu W; Tu S; Ni H; Zhang G; Zhao X; Sun J; Chen W; Song J; Shao M; Tu J; Xia L; He W; Zhu Q; Li K; Yao H; Wu J; Fu L; Jiang W; Zhang H; Lin J; Li B; Tong Z; Windsor J; Liu Y; Li W;
Intensive Care Med; 2022 Jul; 48(7):899-909. PubMed ID: 35713670
[TBL] [Abstract][Full Text] [Related]
11. Effect of extracellular vesicles of
Keyhani G; Mahmoodzadeh Hosseini H; Salimi A
Iran J Microbiol; 2022 Feb; 14(1):90-96. PubMed ID: 35664711
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of Thymosin α1 in the treatment of hepatitis B virus-related acute-on-chronic liver failure: a randomized controlled trial.
Chen JF; Chen SR; Lei ZY; Cao HJ; Zhang SQ; Weng WZ; Xiong J; Lin DN; Zhang J; Zheng YB; Gao ZL; Lin BL
Hepatol Int; 2022 Aug; 16(4):775-788. PubMed ID: 35616850
[TBL] [Abstract][Full Text] [Related]
13. Hypofractionated Radiation Therapy Combined With Weekly Chemotherapy in Patients With Unresectable or Recurrent Thymic Epithelial Tumor: A Prospective, Single-Arm Phase 2 Study (GASTO-1042).
Chu C; Liang Y; Lin X; Liu Y; Liu S; Guo J; Wang D; Wang J; Liu H; Qiu B
Int J Radiat Oncol Biol Phys; 2022 Sep; 114(1):89-98. PubMed ID: 35598797
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
